GINRAM ENDOCIC SINGLE OVAL PORT (MODEL NO. 720195)

• K Number: K992926
• Device Name: GINRAM ENDOCIC SINGLE OVAL PORT (MODEL NO. 720195)
• Manufacturer: RI MOS. S.R.L.
• Date Cleared: 1999-10-26 ( 56 days)
• Product Code: HHK
• Regulation Number: 884.1175

Intended Use

For endometrial sampling for histologic biopsy of the uterine mucosal lining including post menopausal patients.

Device Description

The RI. MOS. s.r.l. curette operates manually by applied vacuum suction and is a sterile single-use disposable device.

Predicate Devices

K991895

Reference Devices

Not Found

AI/ML (Artificial Intelligence / Machine Learning)

No
The device description and performance studies indicate a manually operated, single-use device with no mention of AI/ML terms or functionalities.

Therapeutic

No.
The device is intended for sampling and biopsy, which are diagnostic procedures, not therapeutic.

Diagnostic

Yes
The device is used for "histologic biopsy," which is a diagnostic procedure to examine tissue for disease.

SaMD (Software as a Medical Device)

No

The device description explicitly states it is a manual curette that operates by applied vacuum suction and is a sterile single-use disposable device, indicating it is a physical hardware device.

IVD (In Vitro Diagnostic)

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

• Intended Use: The intended use is "For endometrial sampling for histologic biopsy of the uterine mucosal lining". This describes a procedure to collect a sample from the body.
• Device Description: The device is a manual curette that operates by vacuum suction to collect tissue. This is a tool for sample collection, not for testing the sample in vitro.
• Lack of In Vitro Testing: There is no mention of the device being used to perform tests on the collected sample outside of the body. IVD devices are specifically designed to analyze samples like blood, urine, tissue, etc., in vitro (in a test tube or other artificial environment) to provide diagnostic information.

This device is a medical device used for a sampling procedure, which is a step that might precede an in vitro diagnostic test (like a histological examination of the collected tissue), but the device itself is not the IVD.

PCCP (Predetermined Change Control Plan) Authorized

N/A

Overview

Intended Use / Indications for Use

For endometrial sampling for histologic biopsy of the uterine mucosal lining including post menopausal patients.

Product codes

85 HHK

Device Description

The RI MOS. s.r.l. curette operates manually by applied vacuum suction and is a sterile single-use disposable device.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

uterine mucosal lining

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

A clinical sampling study was conducted to evaluate Endocic's design for safe and effective collection of endometrial tissue samples by aspiration. Results showed sufficient amount and grade of tissue collection. No perforations occurred and no adverse events were reported. Safety tests were conducted and passed in accordance with the relevant sections of ISO 10993.

Key Metrics

Not Found

Predicate Device(s)

K991895

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

Regulation Number and Section

§ 884.1175 Endometrial suction curette and accessories.

(a)
Identification. An endometrial suction curette is a device used to remove material from the uterus and from the mucosal lining of the uterus by scraping and vacuum suction. This device is used to obtain tissue for biopsy or for menstrual extraction. This generic type of device may include catheters, syringes, and tissue filters or traps.(b)
Classification. Class II (performance standards).

Summary

0

001 26 1999

Section 8

510 (k) Summary

K992926

This summary of 510(k) safety and effectiveness information is submitted in accordance with the requirements of the Safe Medical Devices Act of 1990 and 21 C.F.R. §807.92.

1. The submitter of this premarket notification is:

Adena S. Riemer Associate EXPERTech Associates, Inc. 100 Main Street, Suite 120 Concord, MA 01742 Tel: [phone]

l'ax: [phone]

This summary was prepared on August 27, 1999.

• 2. The name of the RI. MOS. s.r.l. device is GINRAM® Endocic. The common name is curette, and the classification name is Endometrial suction curette.
• 3. The above device is substantially equivalent to the RI. MOS. s.r.l. device GINRAM® Rampipella, K991895, clearance date August 12, 1999.
• 4. The RI MOS. s.r.l. curette operates manually by applied vacuum suction and is a sterile single-use disposable device.
• 5. The device is intended for endometrial sampling for histologic biopsy of the uterine mucosal lining or in patients with cervical stenosis.
• 6. The technological characteristics are the same or similar to those found with the predicate device.
• 7. A clinical sampling study was conducted to evaluate Endocic's design for safe and effective collection of endometrial tissue samples by aspiration. Results showed sufficient amount and grade of tissue collection. No perforations occurred and no adverse events were reported. Safety tests were conducted and passed in accordance with the relevant sections of ISO 10993.

28

1

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Ri. Mos. s.r.l. c/o Ms. Adena S. Riemer EXPERTech Associates, Inc. 100 Main Street, Suite 120 Concord, MA 01742

26 1999

Re: K992926 RI. MOS. s.r.l. GINRAM® Endocic Dated: August 30, 1999 Received: August 31, 1999 Regulatory Class: II 21 CFR 5884.1175/Procode: 85 HHK

Dear Ms. Riemer:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

.

If your device is classified (see above) into ether class II (Special Controls) or dass III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will vertify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vilto diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone], or at its internet address "http://www.fda.gov/cdm/dsma/dsmamain.html".

Sincerely yours,

CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

Image /page/1/Picture/13 description: The image shows a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the edge. Inside the circle is a stylized image of an eagle with three lines representing its wings. The eagle is facing to the right.

2

Indications for Use Statement

| 510(k) Number

(if known)	K992926
Device Name	RI. MOS. s.r.l. GINRAM® Endocic
Indications for Use	For endometrial sampling for histologic biopsy
of the uterine mucosal lining including post
menopausal patients.

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

OR

Over-The-Counter Use __ (Optional Format 1-2-96)

(Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological De 510(k) Number_